Detection of specific IgM antibody in the investigation of an outbreak of pneumonia due to Legionella pneumophila serogroup 1  F. de Ory, J.M. Echevarría,

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Table 4 Comparison of frequencies of Legionella pneumophila serogroup 1 urinary antigen results and antibody titer results among patients with Pontiac.
Laboratory diagnosis and biosafety issues of biological warfare agents
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.
L. Boyanova  Clinical Microbiology and Infection 
Approach to diagnosis of infective endocarditis
Herpes zoster in non-hospitalized children
Atypical respiratory pathogens
C.-S. Lee, J.-H. Lee  Clinical Microbiology and Infection 
R. Cantón  Clinical Microbiology and Infection 
Development and evaluation of a multiplex test for the detection of atypical bacterial DNA in community-acquired pneumonia during childhood  J.A. Carrillo,
Link between intracellular pathogens and cardiovascular diseases
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Chlamydia trachomatis infections in heterosexuals attending sexually transmitted disease clinics in Slovenia  D. Kese, M. Maticic, M. Potocnik  Clinical.
Toxoplasmic lymphadenitis—clinical and serologic profile
How to evaluate and predict the epidemiologic impact of antibiotic use in humans: the pharmacoepidemiologic approach  D. Guillemot  Clinical Microbiology.
In vitro activity, postantibiotic effect and human monocyte activity of grepafloxacin against Legionella species  Jacques Dubois, Claude St-Pierre  Clinical.
Isospora belli infection in a patient with non-Hodgkin's lymphoma
Epidemiological investigation of a case of nosocomial Legionnaires' disease in Taiwan: implications for routine environmental surveillance  S.T. Chien,
Vector control: a cornerstone in the malaria elimination campaign
F.R. Gómez, E.P. de la Llave, J.M. García-Lechuz Moya 
Standardization and quality assurance for antimicrobial resistance surveillance of Streptococcus pneumoniae and Staphylococcus aureus within the European.
C-3′Quaternary Ammonium Cephems, a New Wave of Cephalosporins
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
F. Grill, P. Muñoz, R. Jofre, E. Bouza 
Cephalosporins: a pharmacological update
Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels  B. Sarov, L. Novack, N.
Laboratory diagnosis and biosafety issues of biological warfare agents
Improved isolation of Stenotrophomonas maltophilia from the sputa of patients with cystic fibrosis using a selective medium  M. Denton, M.J. Hall, N.J.
The occurrence of Legionella species other than Legionella pneumophila in clinical and environmental samples in Denmark identified by mip gene sequencing.
Uncommon opportunistic fungi: new nosocomial threats
Comparison of clinical and environmental isolates of Legionella pneumophila obtained in the UK over 19 years  T.G. Harrison, N. Doshi, N.K. Fry, C.A.
Levofloxacin in the treatment of ventilator-associated pneumonia
G. Pappas  Clinical Microbiology and Infection 
Mathematical modeling of Clostridium difficile infection
Metagenomics and probiotics
Effect of antioxidants on the immune response of Helicobacter pylori
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Erythromycin susceptibility of viridans streptococci from the normal throat flora of patients treated with azithromycin or clarithromycin  King A. , Bathgate.
Laboratory diagnosis of Clostridium difficile disease
Recent developments in staphylococcal scalded skin syndrome
S8 – S47 and O50 – O440 Clinical Microbiology and Infection
A. Bryskier  Clinical Microbiology and Infection 
Clinical microbiological case: poor radiologic evolution of pulmonary tuberculosis in a heart transplant patient  F. Gavilán, J. Torre-Cisneros, M.A.
T.M. File  Clinical Microbiology and Infection 
Community-acquired pneumonia: epidemiologic and clinical consideration
Training in infectious diseases and tropical medicine in Britain
Evaluation of eight commercial tests for Mycoplasma pneumoniae antibodies in the absence of acute infection  R. Nir-Paz, A. Michael-Gayego, M. Ron, C.
Fibronectin concentrations in catheter sepsis
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
Clinical infection services—the Leiden experience
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
Evaluation of the performance of the Helico Blot 2
Detection of IgA and low-avidity IgG antibodies for the diagnosis of recent active toxoplasmosis  José Gutiérrez, María Rodríguez, Gonzalo Piédrola, María.
The atypical pneumonias: clinical diagnosis and importance
J.J. Keller, M.-C. Tsai, C.-C. Lin, Y.-C. Lin, H.-C. Lin 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
New oral cephalosporins in pediatric community-acquired infections
N. Markeas, G. Stamos, I. Paraskakis, A. Giokas, G. Pistevos 
G.C. Schito  Clinical Microbiology and Infection 
J.A. Pérez-Molina, F. Fernández  Clinical Microbiology and Infection 
Impact of antibiotic restrictions: the patient's perspective
Enhanced isolation of Legionella species from composted material
Localized Mycobacterium avium complex infection in a patient on HAART
The future of diagnostic bacteriology
Presentation transcript:

Detection of specific IgM antibody in the investigation of an outbreak of pneumonia due to Legionella pneumophila serogroup 1  F. de Ory, J.M. Echevarría, C. Pelaz, A. Tellez, M.Å. Mateo Aubry-Damon, J. López  Clinical Microbiology and Infection  Volume 6, Issue 2, Pages 64-68 (February 2000) DOI: 10.1046/j.1469-0691.2000.00050.x Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Timing of the IgM antibody response measured by IIF among the 152 patients with pneumonia included in Table 1. Groups: 1, confirmed; 2, presumptive; 3, seroconversion to low titer; 4, low titer, no, seroconversion; 5, no response. Clinical Microbiology and Infection 2000 6, 64-68DOI: (10.1046/j.1469-0691.2000.00050.x) Copyright © 2000 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.